Back to VP VANGUARD PORTFOLIO MANAGEMENT LLC

LXEOLXEO
2 quarters

Position history for VPVANGUARD PORTFOLIO MANAGEMENT LLC's holdings in LEXEO THERAPEUTICS INC

Yes. Vanguard Portfolio Management holds 613,826 shares of LXEO (Lexeo Therapeutics), worth $2.9M, as of its Q2 2026 13F filing. It increased the position by 36,634 shares (+6.4%) from Q1 2026. Vanguard Portfolio Management has held LXEO in every 13F on record since Q1 2026, 2 quarterly filings.

Current Value

$2.9M

Current Shares

613,826

Total Value Change

-$455,722

Total Shares Change

+36,634

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
613,826
+6.3%
$2.9M0.0%$4.66
28
2026-Q1
First report
577,192
-
$3.3M0.0%$5.74
0

Other major holders of LXEO: Janus Henderson Group Ltd., RA CAPITAL MANAGEMENT, L.P., BlackRock, Inc., ADAGE CAPITAL PARTNERS GP, L.L.C.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used